March 23, 2011
Terumo Cardiovascular Systems Corp. will forfeit $35 million in profits and cease production of several cardiovascular devices to resolve allegations in Michigan that it violated manufacturing and medical device reporting standards, the U.S. Food and Drug Administration said Tuesday.